CIK 0000744218
- Large accelerated filer
Celldex Therapeutics, Inc.
Sign in to watch- Ticker
- CLDX
- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 133191702
- Phone
- +1 908-200-7500
- Business address
- 53 FRONTAGE ROAD, SUITE 220, HAMPTON, NJ, 08827
- Former names
- AVANT IMMUNOTHERAPEUTICS INC, T CELL SCIENCES INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 73 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2015-11-23 | CATLIN AVERY W Sr. VP & CFO | Exercise or conversion · Non-Qualified Stock Option | −25,000 | 0 | ||
| 2015-09-11 | CATLIN AVERY W Sr. VP & CFO | Exercise or conversion | +10,000 | $4.50 | $45K | 35,109 |
| 2015-09-11 | CATLIN AVERY W Sr. VP & CFO | Exercise or conversion · Incentive Stock Option | −10,000 | 7,847 | ||
| 2015-08-25 | ELLBERGER LARRY Director | Purchase | +5,000 | $14.00 | $70K | 53,500 |
| 2015-08-20 | ELLBERGER LARRY Director | Purchase | +5,000 | $15.00 | $75K | 48,500 |
| 2015-08-18 | ELLBERGER LARRY Director | Purchase | +300 | $15.93 | $5K | 38,800 |
| 2015-08-18 | ELLBERGER LARRY Director | Purchase | +2,200 | $15.94 | $35K | 41,000 |
| 2015-08-18 | ELLBERGER LARRY Director | Purchase | +2,500 | $15.96 | $40K | 43,500 |
| 2015-08-13 | ELLBERGER LARRY Director | Purchase | +5,000 | $16.59 | $83K | 38,500 |
| 2015-08-13 | Marucci Anthony S President and CEO | Purchase | +5,800 | $16.81 | $97K | 50,028 |
| 2015-06-15 | CATLIN AVERY W Sr. VP & CFO | Exercise or conversion | +25,000 | $8.52 | $213K | 49,609 |
| 2015-06-15 | CATLIN AVERY W Sr. VP & CFO | Sale | −25,000 | $24.59 | $615K | 24,609 |
| 2015-06-15 | CATLIN AVERY W Sr. VP & CFO | Exercise or conversion · Non-Qualified Stock Option | −25,000 | 0 | ||
| 2015-06-10 | PEPIN RONALD Sr. VP & CBO | Grant or award · Incentive Stock Option | +92,000 | 92,000 | ||
| 2015-06-10 | CATLIN AVERY W Sr. VP & CFO | Grant or award · Incentive Stock Option | +92,000 | 92,000 | ||
| 2015-06-10 | Davis Thomas Andrew Executive VP & CMO | Grant or award · Incentive Stock Option | +116,500 | 116,500 | ||
| 2015-06-10 | KELER TIBOR Executive VP & CSO | Grant or award · Incentive Stock Option | +116,500 | 116,500 | ||
| 2015-06-10 | Marucci Anthony S President & CEO | Grant or award · Incentive Stock Option | +280,000 | 280,000 | ||
| 2015-06-10 | van den Broek Richard Director | Grant or award | +6,500 | 8,500 | ||
| 2015-06-10 | van den Broek Richard Director | Grant or award · Non-Qualified Stock Option (right to buy) | +10,300 | 10,300 |
Page 21 of 32 · 629 trades